| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11030624 | Clinical Neurology and Neurosurgery | 2018 | 6 Pages |
Abstract
CSF protein biomarkers remain normal despite long PD duration, severe disability, and chronic STN-DBS. They cannot be used for PD staging or prognostication but may indicate brain damage caused by other pathological factors.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Radu Constantinescu, Kaj Blennow, Lars Rosengren, Barbro Eriksson, Thordis Gudmundsdottir, Yvonne Jansson, Bo Johnels, Annika Renck, Filip Bergquist,